Appropriateness of empiric antimicrobial therapy with imipenem/colistin in severe septic patients: observational cohort study
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1476-0711
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Appropriateness of empiric antimicrobial therapy with imipenem/colistin in severe septic patients: observational cohort study ; volume:17 ; number:1 ; day:16 ; month:11 ; year:2018 ; pages:1-11 ; date:12.2018
Annals of clinical microbiology and antimicrobials ; 17, Heft 1 (16.11.2018), 1-11, 12.2018
- Creator
-
Trifi, Ahlem
Abdellatif, Sami
Abdennebi, Cyrine
Daly, Foued
Nasri, Rochdi
Touil, Yosr
Ben Lakhal, Salah
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12941-018-0292-7
- URN
-
urn:nbn:de:101:1-2019010102344534124884
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:55 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Trifi, Ahlem
- Abdellatif, Sami
- Abdennebi, Cyrine
- Daly, Foued
- Nasri, Rochdi
- Touil, Yosr
- Ben Lakhal, Salah
- SpringerLink (Online service)
Other Objects (12)
High adsorption capacity of hemoperfusion on imipenem in critically ill patients with septic shock: a case report
Cost-Effectiveness of Imipenem/Cilastatin/Relebactam Compared with Colistin in Treatment of Gram-Negative Infections Caused by Carbapenem-Non-Susceptible Organisms
In vitro activities of colistin, imipenem and ceftazidime against drug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii isolates in the south of Iran
Upstream region of OprD mutations in imipenem-resistant and imipenem-sensitive Pseudomonas isolates
Correction to: Cost-Effectiveness of Imipenem/Cilastatin/Relebactam Compared with Colistin in Treatment of Gram-Negative Infections Caused by Carbapenem-Non-Susceptible Organisms
Ursolic acid inhibits colistin efflux and curtails colistin resistant Enterobacteriaceae
Pharmakokinetik von Ceftriaxon und Imipenem/Cilastatin
Activity of imipenem/relebactam and comparators against KPC-producing Klebsiella pneumoniae and imipenem-resistant Pseudomonas aeruginosa
Comparison of a Fully Empiric and a Semi-Empiric Noise Modeling Approach for a Cargo-UAV
Pharmakokinetische Untersuchungen zu Imipenem bei chirurgischen Patienten
Kurzzeitprophylaxe mit Imipenem/Cilastatin nach Sectio caesarea
Transcriptome profiling in imipenem-selected Acinetobacter baumannii
High adsorption capacity of hemoperfusion on imipenem in critically ill patients with septic shock: a case report
Cost-Effectiveness of Imipenem/Cilastatin/Relebactam Compared with Colistin in Treatment of Gram-Negative Infections Caused by Carbapenem-Non-Susceptible Organisms
In vitro activities of colistin, imipenem and ceftazidime against drug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii isolates in the south of Iran
Upstream region of OprD mutations in imipenem-resistant and imipenem-sensitive Pseudomonas isolates
Correction to: Cost-Effectiveness of Imipenem/Cilastatin/Relebactam Compared with Colistin in Treatment of Gram-Negative Infections Caused by Carbapenem-Non-Susceptible Organisms
Ursolic acid inhibits colistin efflux and curtails colistin resistant Enterobacteriaceae
Pharmakokinetik von Ceftriaxon und Imipenem/Cilastatin
Activity of imipenem/relebactam and comparators against KPC-producing Klebsiella pneumoniae and imipenem-resistant Pseudomonas aeruginosa
Comparison of a Fully Empiric and a Semi-Empiric Noise Modeling Approach for a Cargo-UAV
Pharmakokinetische Untersuchungen zu Imipenem bei chirurgischen Patienten
Kurzzeitprophylaxe mit Imipenem/Cilastatin nach Sectio caesarea
Transcriptome profiling in imipenem-selected Acinetobacter baumannii
High adsorption capacity of hemoperfusion on imipenem in critically ill patients with septic shock: a case report
Cost-Effectiveness of Imipenem/Cilastatin/Relebactam Compared with Colistin in Treatment of Gram-Negative Infections Caused by Carbapenem-Non-Susceptible Organisms
In vitro activities of colistin, imipenem and ceftazidime against drug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii isolates in the south of Iran
Upstream region of OprD mutations in imipenem-resistant and imipenem-sensitive Pseudomonas isolates
Correction to: Cost-Effectiveness of Imipenem/Cilastatin/Relebactam Compared with Colistin in Treatment of Gram-Negative Infections Caused by Carbapenem-Non-Susceptible Organisms
Ursolic acid inhibits colistin efflux and curtails colistin resistant Enterobacteriaceae
Pharmakokinetik von Ceftriaxon und Imipenem/Cilastatin
Activity of imipenem/relebactam and comparators against KPC-producing Klebsiella pneumoniae and imipenem-resistant Pseudomonas aeruginosa
Comparison of a Fully Empiric and a Semi-Empiric Noise Modeling Approach for a Cargo-UAV
Pharmakokinetische Untersuchungen zu Imipenem bei chirurgischen Patienten
Kurzzeitprophylaxe mit Imipenem/Cilastatin nach Sectio caesarea